DAFNA Capital Management as of March 31, 2015
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 71 positions in its portfolio as reported in the March 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Pharmacyclics | 14.1 | $18M | 72k | 255.95 | |
AtriCure (ATRC) | 10.0 | $13M | 637k | 20.49 | |
Auspex Pharmaceuticals | 9.3 | $12M | 121k | 100.27 | |
NxStage Medical | 4.9 | $6.3M | 367k | 17.30 | |
Discovery Laboratories Com New | 4.4 | $5.7M | 4.8M | 1.19 | |
Aerie Pharmaceuticals | 3.9 | $5.0M | 160k | 31.34 | |
Rigel Pharmaceuticals Com New | 3.0 | $4.0M | 1.1M | 3.57 | |
Insulet Corporation (PODD) | 2.7 | $3.5M | 106k | 33.35 | |
Derma Sciences Com Par $.01 | 2.4 | $3.2M | 374k | 8.47 | |
Protalix Biotherapeutics Note 4.500% 9/1 (Principal) | 2.3 | $3.1M | 4.0M | 0.77 | |
Stereotaxis Com New (STXS) | 2.2 | $2.8M | 1.4M | 2.05 | |
Threshold Pharmaceuticals Com New | 2.0 | $2.5M | 626k | 4.06 | |
Insulet Corp Note 2.000% 6/1 (Principal) | 1.9 | $2.4M | 2.4M | 1.00 | |
Achillion Pharmaceuticals | 1.8 | $2.4M | 242k | 9.86 | |
Protalix BioTherapeutics | 1.7 | $2.2M | 1.2M | 1.78 | |
Applied Genetic Technol Corp C | 1.7 | $2.2M | 109k | 19.99 | |
Masimo Corporation (MASI) | 1.7 | $2.2M | 66k | 32.98 | |
Biotelemetry | 1.6 | $2.1M | 236k | 8.85 | |
Otonomy | 1.4 | $1.8M | 50k | 35.36 | |
Clovis Oncology | 1.3 | $1.7M | 23k | 74.23 | |
Novadaq Technologies | 1.3 | $1.7M | 102k | 16.24 | |
Zs Pharma | 1.3 | $1.6M | 39k | 42.07 | |
Ascendis Pharma A S Sponsored Adr Added (ASND) | 1.2 | $1.6M | 94k | 17.35 | |
Neothetics, Inc. Cmn | 1.2 | $1.5M | 187k | 8.21 | |
BioCryst Pharmaceuticals (BCRX) | 1.2 | $1.5M | 167k | 9.03 | |
Essa Pharma | 1.1 | $1.4M | 250k | 5.69 | |
Spectranetics Corporation | 1.1 | $1.4M | 40k | 34.76 | |
Targacept | 1.1 | $1.4M | 465k | 2.97 | |
Zogenix | 0.9 | $1.2M | 854k | 1.37 | |
Syneron Medical Ord Shs | 0.9 | $1.1M | 91k | 12.38 | |
Cytrx Corp Com Par $.001 | 0.8 | $1.0M | 301k | 3.37 | |
Bluebird Bio (BLUE) | 0.7 | $966k | 8.0k | 120.75 | |
Tandem Diabetes Care | 0.7 | $963k | 76k | 12.61 | |
Johnson & Johnson (JNJ) | 0.7 | $946k | 9.4k | 100.64 | |
Cardica | 0.7 | $936k | 1.5M | 0.63 | |
Nuvasive Note 2.750% 7/0 (Principal) | 0.7 | $935k | 760k | 1.23 | |
Encision | 0.6 | $829k | 1.1M | 0.78 | |
XenoPort | 0.6 | $828k | 116k | 7.12 | |
Exactech | 0.6 | $811k | 32k | 25.64 | |
Uniqure B.v. NV SHS (QURE) | 0.6 | $730k | 30k | 24.33 | |
Curis | 0.6 | $720k | 300k | 2.40 | |
Cynapsus Therapeutics | 0.5 | $687k | 717k | 0.96 | |
Caredx (CDNA) | 0.5 | $687k | 124k | 5.55 | |
Check Cap Shs Added | 0.5 | $605k | 110k | 5.50 | |
Cogentix Medical | 0.5 | $593k | 353k | 1.68 | |
Intercept Pharmaceuticals In | 0.4 | $564k | 2.0k | 282.00 | |
Cynapsus Therapeutics | 0.4 | $521k | 544k | 0.96 | |
Minerva Neurosciences | 0.4 | $507k | 101k | 5.00 | |
Keryx Biopharmaceuticals | 0.3 | $443k | 35k | 12.73 | |
RTI Biologics | 0.3 | $424k | 86k | 4.93 | |
Affimed Therapeutics B V | 0.3 | $394k | 63k | 6.30 | |
Epizyme | 0.3 | $376k | 20k | 18.80 | |
Lumenis SHS CL B | 0.3 | $372k | 31k | 11.97 | |
Aldeyra Therapeutics (ALDX) | 0.3 | $356k | 35k | 10.17 | |
Galena Biopharma | 0.3 | $348k | 250k | 1.39 | |
Venaxis | 0.2 | $305k | 658k | 0.46 | |
Cutera (CUTR) | 0.2 | $303k | 24k | 12.90 | |
Genvec Com New | 0.2 | $295k | 100k | 2.95 | |
Lpath Com New | 0.2 | $276k | 112k | 2.47 | |
Bovie Medical Corporation | 0.2 | $239k | 100k | 2.39 | |
Actinium Pharmaceuticals | 0.2 | $222k | 90k | 2.47 | |
Transition Therapeutics Com New | 0.1 | $180k | 26k | 6.82 | |
Nanosphere | 0.1 | $139k | 600k | 0.23 | |
Cas Medical Systems Com Par $0.004 | 0.1 | $134k | 100k | 1.34 | |
Aptose Biosciences Com New | 0.1 | $121k | 22k | 5.43 | |
Chembio Diagnostics Com New | 0.1 | $106k | 26k | 4.03 | |
Fate Therapeutics (FATE) | 0.1 | $99k | 20k | 4.90 | |
Tonix Pharmaceuticals Hldg C Com New | 0.1 | $91k | 14k | 6.32 | |
Globeimmune (GBIM) | 0.1 | $69k | 9.4k | 7.31 | |
Check Cap Ltd-cw20 *w Exp 02/28/202 Added | 0.0 | $55k | 55k | 1.00 | |
Opexa Therapeutics Com New | 0.0 | $0 | 500.00 | 0.00 |